Product
BPaL
1 clinical trial
1 indication
Indication
Multidrug-resistant TuberculosisClinical trial
The 6-month BPaL(M) Regimen for the Treatment of Patients With MDR/RR-TB: Multicenter, Single-arm, Operational Research, Clinical TrialStatus: Recruiting, Estimated PCD: 2027-12-01